Global Pancreatic Cancer Market Is Anticipated to Expand at a 7.60% CAGR During the Forecast Period, Rising from a Value of US$1.7 Bn in 2014 to US$2.9 Bn by 2021
The global pancreatic cancer therapeutics market is largely fueled by the increase in diabetes, rise in global aging population, and the growing prevalence of obesity. The report, titled "Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape", states that the global market for pancreatic cancer is anticipated to expand at a 7.60% CAGR during the forecast period, rising from a value of US$1.7 bn in 2014 to US$2.9...
View full press release